EGFR and PML

  • Number of citations of the paper that reports this interaction (PMID 23563092)
  • 2
  • Data Source:
  • BioGRID (pull down, affinity chromatography technology, imaging technique)

EGFR

PML

Gene Name epidermal growth factor receptor promyelocytic leukemia
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 279 interactors: ABL1 ABL2 ACTA1 ADRBK1 ADRM1 AGTR1 AHNAK AHSA1 AIP AKAP12 ALCAM ALDOA AMH ANKS1A ANKS1B ANXA1 APBA3 APBB1 APBB2 APBB3 APPL1 AR AREG ARF4 ATIC ATP1A1 ATP1B1 ATP5C1 BLK BMX BTC CALM1 CALM2 CALM3 CAMK2A CAMK2G CAMLG CASP1 CAV1 CAV2 CAV3 CBL CBLB CBLC CBR1 CD44 CD59 CD82 CDC25A CDH1 CEACAM1 CEBPB CEND1 CFL1 CISH CLNK CLTA CLTCL1 CMTM8 CNTN2 COL9A3 COX2 CRK CSRP1 CTNNB1 CTNND1 DCBLD2 DCN DCTN2 DEGS1 DNAJC4 DOK2 DOK4 DOK5 DOK6 DUSP3 DYNC1H1 EEF1G EGF ELF3 EPB41 EPHA2 EPPK1 EPS15 EPS8 ERBB2 ERBB3 ERBB4 EREG ERRFI1 ESR1 EZR FAH FAS FBXO25 FER FES FKBP4 FKBP8 FN1 GAB1 GABARAPL2 GAPDH GNAI2 GOT1 GPM6B GRB10 GRB14 GRB2 GRB7 HBEGF HEXIM1 HGS HIST3H3 HOXC10 HSP90B1 HSPA1A HSPA4 HSPA8 HTT ICAM1 INPPL1 IRS1 IRS4 ITGA5 JAK2 JUP KCTD9P2 KRT17 KRT18 KRT7 KRT8 LYN MAP2K1 MAP3K12 MAP3K14 MAP4K1 MAPK1 MAPK14 MAPK8IP1 MAPK8IP2 MAST1 MATR3 MDH1 MEGF6 MET MGARP MOB4 MUC1 NCAM1 NCK1 NCK2 NDN NEDD4 NUMB NUMBL OAZ1 OLFM1 PAK1 PCNA PDCD6IP PDGFRB PDK3 PIK3C2A PIK3C2B PIK3R1 PIK3R2 PIK3R3 PIN4 PITPNA PKIA PLCG1 PLCG2 PLD1 PLD2 PLEC PLSCR1 PML PPP5C PRCC PRDX1 PRKACA PRKAR1A PRKAR1B PRKCA PRKCB PRKCD PRKD1 PSMA7 PSMD4 PTGDS PTK2 PTK2B PTK6 PTPN1 PTPN11 PTPN12 PTPN2 PTPN6 PTPRJ PTPRS RAB3A RAP1GDS1 RASA1 RGS16 RIN2 RIPK1 RNF115 RNF126 RQCD1 RUSC2 S100A7 S100A9 SCAMP1 SCAMP3 SEC13 SEPP1 SFN SGSM2 SH2B1 SH2B3 SH2D1A SH2D2A SH2D3A SH3BGRL3 SHC1 SHC2 SHC3 SLA SLC3A2 SLC9A3R1 SMURF2 SNRPD2 SNX1 SNX2 SNX4 SNX6 SOCS1 SOCS3 SOCS4 SOCS5 SOCS7 SORBS2 SOS1 SOS2 SPARCL1 SPCS2 SRC STAM2 STAT1 STAT3 STAT5A STAT5B STIP1 SYK TGFA TJP1 TLN1 TMCO3 TNC TNK2 TNS4 TPI1 TPM1 TRPV1 TUBA1A TUBA4A UBB UBE2V2 UCHL1 UROD VAPA VAV1 VAV2 VAV3 XRCC6 YWHAZ ZAP70 ZPR1 101 interactors: ADH1B ANKRD2 ARID3A ARNT ATF2 ATXN1 AURKA AXIN1 BANP BCL2 BCL6 CASP8AP2 CCNT1 CDK1 CDK2 CDK6 CHFR CREBBP CSNK2A1 DAXX EGFR EIF4E ELF4 EP300 FOS GATA2 HDAC1 HDAC2 HDAC3 HHEX HIPK2 HTT KAT5 KAT6A MAPK11 MAPK14 MDM2 MED7 MXD1 MYB MYC NCOA2 NCOR1 NCOR2 NFKB1 NR3C1 NR4A1 PAWR PAXIP1 PCBD2 PIAS1 PIAS2 PIN1 PLAGL1 PLSCR1 POLR2E PPARG PSMA3 RARA RB1 RBX1 RELA RNF111 RNF125 RNF4 RPL11 RXRA SENP2 SH3GL1 SIAH2 SIN3A SIRT1 SKI SMAD3 SP1 SP100 SRF STAT3 SUMO1 SUMO2 SUMO3 SUV39H1 SYNE2 TDG TERF2IP TGFBR1 TGFBR2 TGIF1 THRA TOPBP1 TP53 TP63 TP73 TRIM24 TRIM27 TRIM69 UBE2I UBE2U UBE3A ZBTB16 ZFYVE9
Entrez ID 1956 5371
HPRD ID 00579 00023
Ensembl ID ENSG00000146648 ENSG00000140464
Uniprot IDs E9PFD7 P00533 P29590
PDB IDs 1DNQ 1DNR 1IVO 1M14 1M17 1MOX 1NQL 1XKK 1YY9 1Z9I 2EB2 2EB3 2EXP 2EXQ 2GS2 2GS6 2GS7 2ITN 2ITO 2ITP 2ITQ 2ITT 2ITU 2ITV 2ITW 2ITX 2ITY 2ITZ 2J5E 2J5F 2J6M 2JIT 2JIU 2JIV 2KS1 2M20 2RF9 2RFD 2RFE 2RGP 3B2U 3B2V 3BEL 3BUO 3C09 3G5V 3G5Y 3GOP 3GT8 3IKA 3LZB 3NJP 3OB2 3OP0 3P0Y 3PFV 3POZ 3QWQ 3UG1 3UG2 3VJN 3VJO 3VRP 3VRR 3W2O 3W2P 3W2Q 3W2R 3W2S 3W32 3W33 4G5J 4G5P 4HJO 4I1Z 4I20 4I21 4I22 4I23 4I24 4JQ7 4JQ8 4JR3 4JRV 4KRL 4KRM 4KRO 4KRP 4LI5 4LL0 1BOR
Enriched GO Terms of Interacting Partners?
Tagcloud ?
12q  12q21  14q31  15q25  16q23  18p  19q13  20p12  20pq  20q12  21q21  3p14  4pq  5p14  5q14  6p12  7p12  8q23  cardia  cdkn2  fist  gej  mlvi2  mts1  nrasl3  parentheses  ptpn1  rca1  xpq  xq25 
anthracycline  apl  approaches  appropriately  arsenic  corepressors  curable  cure  deacetylase  effectiveness  explain  explains  incorporation  minority  oncogenes  pathogenetic  plzf  progranulocytic  promoters  ra  rar  recruit  refinement  relapsed  repression  safe  timed  trioxide  vast 
Tagcloud (Difference) ?
12q  12q21  14q31  15q25  16q23  18p  19q13  20p12  20pq  20q12  21q21  3p14  4pq  5p14  5q14  6p12  7p12  8q23  cardia  cdkn2  fist  gej  mlvi2  mts1  nrasl3  parentheses  ptpn1  rca1  xpq  xq25 
anthracycline  apl  approaches  appropriately  arsenic  corepressors  curable  cure  deacetylase  effectiveness  explain  explains  incorporation  minority  oncogenes  pathogenetic  plzf  progranulocytic  promoters  ra  rar  recruit  refinement  relapsed  repression  safe  timed  trioxide  vast 
Tagcloud (Intersection) ?